Advertisement
Advertisement

APGE

APGE logo

Apogee Therapeutics, Inc. Common Stock

133.25
USD
Sponsored
-0.29
-0.22%
Jul 08, 16:00 UTC -4
Closed
exchange

After-Market

133.92

+0.67
+0.50%

APGE Earnings Reports

Positive Surprise Ratio

APGE beat 6 of 12 last estimates.

50%

Next Report

Date of Next Report
Aug 10, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/
-$1.09
Implied change from Q1 26 (Revenue/ EPS)
--
/
+2.83%
Implied change from Q2 25 (Revenue/ EPS)
--
/
-2.68%

Apogee Therapeutics, Inc. Common Stock earnings per share and revenue

On May 11, 2026, APGE reported earnings of -1.06 USD per share (EPS) for Q1 26, beating the estimate of -1.12 USD, resulting in a 5.65% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +1.89% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 9 analysts forecast an EPS of -1.09 USD, with revenue projected to reach -- USD, implying an increase of 2.83% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Replimune Group, Inc.
Report Date
Jun 29, 2026 For Q4 26
Estimate
-$0.72
Actual
-$0.76
Surprise
-4.52%
logo
Beyond Air, Inc. Common Stock
Report Date
Jun 26, 2026 For Q4 26
Estimate
-$0.57
Actual
-$0.63
Surprise
-9.00%
FAQ
For Q1 2026, Apogee Therapeutics, Inc. Common Stock reported EPS of -$1.06, beating estimates by 5.65%, and revenue of $0.00, 0% as expectations.
The stock price moved up 1.89%, changed from $83.03 before the earnings release to $84.60 the day after.
The next earning report is scheduled for Aug 10, 2026.
Based on 9 analysts, Apogee Therapeutics, Inc. Common Stock is expected to report EPS of -$1.09 and revenue of -- for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement